Pediatric COVID Shots, Still Under EUA, Would Be Vulnerable In Anti-Vax HHS

Pulling a product that was granted an emergency use authorization is easier than pulling a fully licensed vaccine, which could place Pfizer and Moderna’s COVID-19 vaccine pediatric indications at risk, along with Novavax’s vaccine in all age groups.